TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells

Thrombosis and Haemostasis

Volumn 83, Issue 4, 2000, Pages 598-604

  Eliassen, Liv Tone ^a   Rekdal, O ^b   Svendsen, J S ^b   Osterud B ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NONE

Author keywords

Leukocytes; Molecular modelling; Tissue factor; TNF peptides

Indexed keywords

CATHEPSIN G; CYTOKINE; ELASTASE; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; POLYCLONAL ANTIBODY; THROMBOPLASTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BLOOD CELL; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; GRANULOCYTE; HUMAN; HUMAN CELL; MOLECULAR MODEL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034088659     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613870     Document Type: Article

References (31)

1. Vasalli P, Grau GE, Piguet PF. TNF in autoimmune diseases, graft-versus-host reaction, and pulmonary fibrosis. Immunol-Ser 1992; 56: 409-30.
2. Fiers W. Biologic therapy with TNF: preclinical studies. In Biologic theraphy of cancer: principles and practice. De Vita V Jr, Hellman S, Rosenberg ST, eds. Philadelphia: J. P. Lippincott Company 1995; 295-327.
3. Rothwell NJ, Gridle RF. Metabolic and nutritional effects of TNF. In Tumor necrosis factors. The molecular structures and their emerging role in medicine. Beutler B, ed. New York: Raven Press 1992; 237-54.
4. Tracy KJ. TNF and other cytokines in the metabolism of septic shock and cachexia. Clin Nutr 1992; 11: 1-11.
5. Wang JM, Bersani L, Mantovani M. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 1987; 138: 1469-74.
6. Ferrante A, Nandoskar M, Walz A, Goh DHB, Kowanko IC. Effects of tumor necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol 1988; 86: 82-91.
7. Klebanoff SJ, Vadas MA, Harlan J M, Sparks LH, Gamble JR, Agosti JM Walterdorph. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986; 136: 4220-5.
8. Dinarello CA, Cannon JG, Wolff SM. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 1986; 163: 1433-50.
9. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 1990; 4: 2860-7.
10. Smith BW, Gamble RJ, dark-Lewis I, Vadas MA. Interleukin-8 induces neutrophil transendothelial migration. Immunol 1991; 72: 65-72.
11. Halvorsen H, Olsen JO, Østerud B. Granulocytes enhance LPS-induccd tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol 1993; 54: 275-82.
12. Rekdal Ø, Konopski Z, Svendsen JS, Winberg JO, Espevik T, Østerud B. The TNF receptors p55 and p75 mediate chemotaxis of PMN induced by TNFa and a TNFa 36-62 peptide. Med Inflamm 1994; 3: 347-52.
13. Rekdal Ø, Østerud B, Svendsen JS, Winberg JO. (1996) Evidence for exclusive role of the p55 tumor necrosis factor (TNF) receptor in mediating the TNF-induced collagenase expression by human dermal fibroblasts. J Invest Dermatol 1996; 107: 565-8.
14. Eck JE, Sprang RS. The structure of tumor necrosis factor-α at 2.6 Å resolution. J Biol Chem 1989; 264: 17595-605.
15. Van Ostade X, Travernier J, Prange T, Fiers W. Localization of the active site of human tumor necrosis factor (hTNF) by mutual analysis. EMBO J 1991; 10: 827-36.
16. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; (Suppl) 21: 77-89.
17. Engstad Sissener C, Lia K, Rekdal Ø, Olsen JO, Østerud B. A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 1995; 58: 575-81.
18. Nacamura K, Powers JC. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates released to the a1-protease inhibitor reactive site. J Biol Chem 1979; 254: 4027-32.
19. Østerud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes. J Leukoc Biol 1992; 51: 462-5.
20. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-3.
21. Nakamura S, Magesi T, Fukuoka M, Kiati K, Kato A, Watanabe N, Niitsu Y. Interaction between novel tumor necrosis factor-α mutants and receptors on tumor and normal cells. Agric Biol Chem 1991; 55: 53-7.
22. Yamagishi JI, Kawashima H, Matsuo N, Ohue M, Yoamayoshi M, Toshikazu F, Kotani H. Mutational analysis of structure-activity relationships in human tumour necrosis factor alpha. Protein Engineering 1990; 3: 713-9.
23. van Ginkel CJ, van Aken WG, Oh JI, Vreeken J. Stimulation of monocyte procoagulant activity by adherence to different surfaces. Br J Haematol 1977; 37 (1): 35-45.
24. Ternisien C, Ramani M, Ollivier V, Khechai F, Vu T, Hakim J, de Prost D. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation. Thromb Haemost 1993: 800-6.
25. Brakebusch C, Nophar Y, Kemper O, Engelmann H, Wallach D. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO J 1992; 11: 943-50.
26. Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russel DA. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine 1995; 7: 26-38.
27. Rathjen DA, Ferrante A, Aston R. Differential effects of small tumour necrosis factor-α peptides on tumour cell cytotoxicit, neutrophil activation and endothelial cell procoagulant activity. Immunology 1993; 80: 293-9.
28. Engelmann H, Holtmann H, Brakebuch C, Avni YS, Sarov I, Nophar Y, Hadas F, Leher O, Wallach D. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 1990; 265: 14497-504.
29. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor. J Exp Med 1990; 171: 415-26.
30. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MAJr, Goeddel DV. The two different receptors for tumor necrosis factor mediate distinct cellular responces. Proc Natl Acad Sci USA 1991; 88: 9292-6.
31. Kumaratilake LM, Rathjen DA, Mack P, Widmer F, Prasertsiriroj V, Ferrante A. A synthetic tumor necrosis factor-agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chahaudi infection in mice. J Clin Invest 1995; 95: 2315-23.